Search This Blog

Thursday, February 21, 2019

Integra LifeSciences targets $2B in revenue by 2022

Integra LifeSciences targets $2B in revenue by 2022 with consistent organic growth of 5%-7%. Targets 28%-30% EBITDA margin by 2022.
https://thefly.com/landingPageNews.php?id=2867789
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)